Finance

Lists
Outlook: 91.7% bullish·0.0% bearish
Go to analysis
PRVA:NASDAQ
Privia Health Group Inc
$24.37
-0.69%
(-0.17) 1D
$24.37
0.00% (0.00)
After hours
Closed: Nov 10, 4:00:00 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PRVA...
Open
$24.54
High
$24.78
Low
$23.67
Mkt. cap
3.11B
Avg. vol.
1.37M
Volume
0.00
P/E ratio
92.36
52-wk high
$28.82
52-wk low
$18.92
EPS
$0.26
Beta
0.76
Shares outstanding
127.77M
No. of employees
1K
Open
$24.54
High
$24.78
Low
$23.67
Mkt. cap
3.11B
Avg. vol.
1.37M
Volume
0.00
P/E ratio
92.36
52-wk high
$28.82
52-wk low
$18.92
EPS
$0.26
Beta
0.76
Shares outstanding
127.77M
No. of employees
1K
News stories
From web sources and news partners
About Privia Health Group Inc
CEO-
Employees1.23K
Founded2007
Headquarters-
SectorHealth Care
IndustryHealth care provider
Analyst ratings
Based on 8 analysts giving stock ratings to PRVA in the past 3 months
Strong buy
Buy
7
Hold
1
Sell
0
12-month forecast
Based on 8 Wall Street analysts offering 12 month price targets for PRVA in the last 3 months.
Highest
Current $24.37
$38.00 (+55.93%)
Average
$30.75 (+26.18%)
Lowest
$24.00 (-1.52%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ryan Halsted
RBC Capital
Buy
Reiterated
$31.00
+27.2%
11/05/2026
Jessica Tassan
Piper Sandler
Buy
Maintained
$38.00
+55.9%
11/06/2026
Gary Taylor
TD Cowen
Buy
Maintained
$31.00
+27.2%
11/06/2026
Elizabeth Anderson CFA
Evercore ISI
Buy
Maintained
$26.00
+6.7%
11/05/2026
Richard Close
Canaccord Genuity
Buy
Maintained
$33.00
+35.4%
11/03/2026
Andrew Mok CFA
Barclays
Hold
Maintained
$24.00
-1.5%
11/03/2026
Unknown Analyst
Jefferies
Buy
Maintained
$30.00
+23.1%
09/16/2026
Jailendra Singh
Truist Financial
Buy
Maintained
$33.00
+35.4%
08/13/2026
Daniel Grosslight
Citi
Buy
Reiterated
$35.00
+43.6%
08/10/2026
David Larsen
BTIG
Buy
Maintained
$35.00
+43.6%
08/09/2026
Sean Dodge
BMO Capital
Buy
Maintained
$30.00
+23.1%
08/07/2026
Ryan Daniels
William Blair
Buy
Reiterated
-
-
08/06/2026
Ryan Langston
TD Cowen
Buy
Maintained
$30.00
+23.1%
05/11/2026
Matthew Shea
Needham
Buy
Reiterated
$30.00
+23.1%
05/07/2026
Lisa Gill
J.P. Morgan
Buy
Maintained
$35.00
+43.6%
03/06/2026
Unknown Analyst
BTIG
Buy
Maintained
$35.00
+43.6%
03/05/2026
Matthew Gillmor CFA
KeyBanc
Buy
Maintained
-
-
02/27/2026
Jack Slevin
Jefferies
Buy
Reiterated
$32.00
+31.3%
02/26/2026
Last report
Nov 5, 2026
Fiscal period
Q3 2026
$0.21 / $0.24
-11.76%miss
Revenue / Est. (USD)
656.96M / 610.62M
+7.59%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
541.17M
603.85M
632.63M
656.96M
Cost of goods sold
491.52M
543.54M
569.84M
588.52M
Cost of revenue
491.52M
543.54M
569.84M
588.52M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
35.72M
49.61M
47.66M
44.39M
Operating expense
38.38M
52.89M
51.02M
47.90M
Total operating expenses
529.90M
596.42M
620.86M
636.42M
Operating income
11.28M
7.42M
11.77M
20.54M
Other non operating income
-
-
3.31M
-
EBT including unusual items
13.37M
9.31M
16.75M
22.26M
EBT excluding unusual items
13.37M
9.31M
16.75M
22.26M
Income tax expense
2.79M
5.60M
7.02M
7.67M
Effective tax rate
20.84%
60.15%
41.89%
34.45%
Other operating expenses
-
-
-
-
Net income
9.15M
3.06M
9.05M
13.49M
Net profit margin
1.69%
0.51%
1.43%
2.05%
Earnings per share
0.25
0.19
0.19
0.21
Interest and investment income
2.09M
1.89M
1.67M
1.72M
Interest expense
-
-
-
-
Net interest expenses
2.09M
1.89M
1.67M
1.72M
Depreciation and amortization charges
2.66M
3.28M
3.36M
3.50M
EBITDA
13.94M
10.70M
15.13M
24.04M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps